Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Mar;88(3):1167-73.
doi: 10.1210/jc.2002-020918.

The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone

Affiliations
Clinical Trial

The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone

Karen L Herbst et al. J Clin Endocrinol Metab. 2003 Mar.

Abstract

In hypogonadal men, testosterone (T) in replacement dosages is known to increase fat-free mass (lean mass) and decrease fat mass. In young eugonadal men, similar dosages of T increase lean mass, but much higher dosages of T are required to decrease total body fat mass. Current T-based male hormonal contraceptive regimens include a second agent, such as a progestin, to maximize inhibition of pituitary gonadotropins and improve efficacy. To study the effect of such combinations on body composition, we randomized healthy, young, eugonadal men into four combinations of exogenous T and the progestin, levonorgestrel (LNG): 1) 100 mg T enanthate, im, weekly plus 125 micro g LNG, orally, daily (T+LNG); 2) T plus placebo LNG (T alone); 3) placebo T plus LNG (LNG alone); and 4) placebo T plus placebo LNG (placebo). We then analyzed body composition by dual energy x-ray absorptiometry after 4 and 8 wk of treatment. T+LNG significantly increased total lean mass after 4 and 8 wk of treatment (3.5 +/- 0.9% and 4.2 +/- 1.2%, respectively; P < 0.05) and truncal lean mass after 4 and 8 wk of treatment (4.7 +/- 0.9% and 5.0 +/- 0.9%, respectively; P < 0.05) compared with baseline and placebo. T alone also increased total and truncal lean mass significantly compared with placebo after 4 wk of treatment, but not compared with baseline (3.3 +/- 1.4% and 3.2 +/- 2.3%, respectively; P < 0.05 vs. placebo), suggesting an additive effect of T and LNG to increase lean mass. Fat mass significantly decreased in the abdomen in men administered T alone compared with LNG alone (-4.9 +/- 2.8%; P < 0.05). Fat mass significantly increased in the abdomen with LNG alone (4.1 +/- 1.0%; P < 0.05) compared with baseline and was unchanged with the combination of T+LNG, suggesting that LNG attenuates the decrease in fat mass seen with T alone. There was no change in weight or body mass index in any group during the study. This study shows that in young eugonadal men 1) T alone rapidly increases lean mass and decreases fat mass in 4-8 wk; 2) T+LNG rapidly increases lean mass, but has no effect on fat mass; and 3) LNG alone increases fat mass. The favorable profile on body composition by T is, therefore, partially attenuated by the progestin, LNG. These findings suggest that androgen-based male hormonal contraceptives might have favorable effects on body composition. The impact of these changes on cardiovascular risk in normal men needs further study.

PubMed Disclaimer

Similar articles

Cited by

  • Testosterone replacement therapy and cardiovascular risk.
    Gagliano-Jucá T, Basaria S. Gagliano-Jucá T, et al. Nat Rev Cardiol. 2019 Sep;16(9):555-574. doi: 10.1038/s41569-019-0211-4. Nat Rev Cardiol. 2019. PMID: 31123340 Review.
  • Advances in male contraception.
    Page ST, Amory JK, Bremner WJ. Page ST, et al. Endocr Rev. 2008 Jun;29(4):465-93. doi: 10.1210/er.2007-0041. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436704 Free PMC article. Review.
  • Male hormonal contraception: looking back and moving forward.
    Roth MY, Page ST, Bremner WJ. Roth MY, et al. Andrology. 2016 Jan;4(1):4-12. doi: 10.1111/andr.12110. Epub 2015 Oct 9. Andrology. 2016. PMID: 26453296 Free PMC article. Review.
  • The future of male contraception: a fertile ground.
    Khourdaji I, Zillioux J, Eisenfrats K, Foley D, Smith R. Khourdaji I, et al. Transl Androl Urol. 2018 May;7(Suppl 2):S220-S235. doi: 10.21037/tau.2018.03.23. Transl Androl Urol. 2018. PMID: 29928620 Free PMC article. Review.
  • Male contraception.
    Chao J, Page ST, Anderson RA. Chao J, et al. Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):845-57. doi: 10.1016/j.bpobgyn.2014.05.008. Epub 2014 Jun 5. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24947599 Free PMC article. Review.

Publication types

LinkOut - more resources